Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment potential in APOL1-associated nephropathy.

Current opinion in nephrology and hypertension - 1 Sept 2022

Friedman David J, Ma Lijun, Freedman Barry I

Abstract excerpt

PURPOSE OF REVIEW: More than 5 million African-Americans, and millions more in Africa and worldwide, possess apolipoprotein L1 gene (APOL1) high-risk genotypes with an increased risk for chronic kidney disease. This manuscript reviews treatment approaches for slowing the progression of APOL1-associated nephropathy. RECENT FINDINGS: Since the 2010 discovery of APOL1 as a cause of nondiabetic nephropathy in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Interferons

Share to Renal Insufficiency, Chronic

Source

Identifiers

PMID: 35894278
DOI: 10.1097/MNH.0000000000000816

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment potential in APOL1-associated nephropathy.PMID 35894278Read ↗

APOL1 nephropathy - a population genetics success story.Semantic proximity Read ↗

The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.Semantic proximity Read ↗

Target organ damage in African American hypertension: role of APOL1.Semantic proximity Read ↗

Apolipoprotein L1 (APOL1) and Nephropathy.Semantic proximity Read ↗

APOL1 and kidney diseaseSemantic proximity Read ↗

The evolving science of apolipoprotein-L1 and kidney disease.Semantic proximity Read ↗

Apolipoprotein L1 and Kidney Disease in African Americans.Semantic proximity Read ↗

Molecular Mechanisms of APOL1-Associated Kidney Disease.Semantic proximity Read ↗

Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.Semantic proximity Read ↗

APOL1 Nephropathy: From Genetics to Clinical Applications.Semantic proximity Read ↗

Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.Semantic proximity Read ↗

APOL1-associated kidney disease: modulators of the genotype-phenotype relationship.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.